Cancer-suppressive potential of extracts of endemic plant Helichrysum zivojinii: Effects on cell migration, invasion and angiogenesis

Natural Product Communications

Volumn 8, Issue 9, 2013, Pages 1291-1296

  Matić, Ivana Z ^a   Aljančić, Ivana ^b   Vajs, Vlatka ^b   Jadranin, Milka ^b   Gligorijević, Nevenka ^a   Milosavljević, Slobodan ^c   Juranić, Zorica D ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Angiogenesis in vitro; Cytotoxic action; EA.hy926; Helichrysum zivojinii; Invasiveness; MDA MB 231

Indexed keywords

ANTINEOPLASTIC AGENT; HELICHRYSUM ZIVOJINII EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; HELICHRYSUM; HELICHRYSUM ZIVOJINII; HUMAN; HUMAN CELL; IN VITRO STUDY;

HELICHRYSUM;

EID: 84886856412     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1300800927     Document Type: Article

References (39)

1. Bhat TA, Singh RP. (2008) Tumor angiogenesis - A potential target in chemoprevention. Food and Chemical Toxicology, 46, 1334-1345.
2. Mehta RG, Murillo G, Naithani R, Peng X. (2010) Cancer chemoprevention by natural products: How far have we come? Pharmaceutical Research, 27, 950-961.
3. Ramos S. (2008) Cancer chemoprevention and chemotherapy: Dietary polyphenols and signaling pathways. Molecular Nutrition and Food Research, 52, 507-526.
4. Weng CJ, Yen GC. (2012) Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer and Metastasis Reviews, 31, 323-351.
5. Lourens ACU, Viljoen AM, van Heerden FR. (2008) South African Helichrysum species: a review of the traditional uses, biological activity and phytochemistry. Journal of Ethnopharmacology, 119, 630-652.
6. Passalacqua NG, Guarrera PM, De Fine G. (2007) Contribution to the knowledge of the folk plant medicine in Calabria region (Southern Italy). Fitoterapia, 78, 52-68.
7. Sezik E, Yesilada E, Honda G, Takaishi Y, Takeda Y, Tanaka T. (2001) Traditional medicine in Turkey X. Folk medicine in Central Anatolia. Journal of Ethnopharmacology, 75, 95-115.
8. Afoulous S, Ferhout H, Raoelison EG, Valentin A, Moukarzel B, Couderc F, Bouajila J. (2011) Helichrysum gymnocephalum essential oil: chemical composition and cytotoxic, antimalarial and antioxidant activities, attribution of the activity origin by correlations. Molecules, 16, 8273-8291.
9. Aiyegoro OA, Okoh AI. (2010) Preliminary phytochemical screening and in vitro antioxidant activities of the aqueous extract of Helichrysum longifolium DC. BMC Complementary and Alternative Medicine, 10, 21e; doi:10.1186/1472-6882- 10-21.
10. Appendino G, Ottino M, Marquez N,Bianchi F, Giana A, Ballero M, Sterner O, Fiebich BL, Munoz E. (2007) Arzanol, an anti-inflammatory and anti-HIV-1 phloroglucinol α-pyrone from Helichrysum italicum ssp. microphyllum. Journal of Natural Products, 70, 608-612.
11. Bauer J, Koeberle A, Dehm F, Pollastro F, Appendino G, Northoff H, Rossi A, Sautebin L, Werz O. (2011) Arzanol, a prenylated heterodimeric phloroglucinylpyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo. Biochemical Pharmacology, 81, 259-268.
12. Kucukoglu O, Ozturk B, Kamataki T, Topcu Z. (2006) Inhibitory activities of Helichrysum taxa on mammalian type I DNA topoisomerase. Pharmaceutical Biology, 44, 189-193.
13. Rosa A, Deiana M, Atzeri A, Corona G, Incani A, Melis MP, Appendino G, Dessí MA. (2007) Evaluation of the antioxidant and cytotoxic activity of arzanol, a prenylated α-pyrone-phloroglucinol etherodimer from Helichrysum italicum subsp. microphyllum. Chemico-Biological Interactions, 165, 117-126.
14. Yagura T, Motomiya T, Ito M, Honda G, Iida A, Kiuchi F, Tokuda H, Nishino H. (2008) Anticarcinogenic compounds in the Uzbek medicinal plant, Helichrysum maracandicum. Journal of Natural Medicines, 62, 174-178.
15. Bigović D, Savikin K, Janković T, Menković N, Zdunić G, Stanojković T, Djurić Z. (2011) Antiradical and cytotoxic activity of different Helichrysum plicatum flower extracts. Natural Product Communications, 6, 819-822.
16. Oji KA, Shafaghat A. (2012) Constituents and antimicrobial activity of the essential oils from flower, leaf and stem of Helichrysum armenium. Natural Product Communications, 7, 671-674.
17. Matić IZ, Aljančić I, Žižak Ž, Vajs V, Jadranin M, Milosavljević S, Juranić ZD. (2013) In vitro antitumor actions of extracts from endemic plant Helichrysum zivojinii. BMC Complementary and Alternative Medicine, 13, 36e; doi:10.1186/1472-6882-13-36.
18. Liang CC, Park AY, Guan JL. (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols, 2, 329-333.
19. Aranda E, Owen GI. (2009) A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. Biological Research, 42, 377-389.
20. Weng CJ, Yen GC. (2012) Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treatment Reviews, 38, 76-87.
21. Franzen CA, Amargo E, Todorović V, Desai BV, Huda S, Mirzoeva S, Chiu K, Grzybowski BA, Chew TL, Green KJ, Pelling JC. (2009) The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prevention Research (Philadelphia), 2, 830-841.
22. Hu XW, Meng D, Fang J. (2008) Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis, 29, 2369-2376.
23. Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH. (2008) Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicology and Applied Pharmacology, 226, 178-191.
24. Shukla S, Gupta S. (2010) Apigenin: A promising molecule for cancer prevention. Pharmaceutical Research, 27, 962-978.
25. Fang J, Zhou Q, Liu LZ, Xia C, Hu X, Shi X, Jiang BH. (2007) Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis, 28, 858-864.
26. Lamy S, Akla N, Ouanouki A, Lord-Dufour S, Béliveau R. (2012) Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway. Experimental Cell Research, 318, 1586-1596.
27. Dajas F. (2012) Life or death: Neuroprotective and anticancer effects of quercetin. Journal of Ethnopharmacology, 143, 383-396.
28. Huang YT, Hwang JJ, Lee PP, Ke FC, Huang JH, Huang CJ, Kandaswami C, Middleton E Jr, Lee MT. (1999) Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. British Journal of Pharmacology, 128, 999-1010.
29. Zhang H, Zhang M, Yu L, Zhao Y, He N, Yang X. (2012) Antitumor activities of quercetin and quercetin-5′,8-disulfonate in human colon and breast cancer cell lines. Food and Chemical Toxicology, 50, 1589-1599.
30. Chen AY, Chen JC. (2013) A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chemistry, 138, 2099-2107.
31. Kanno S, Tomizawa A, Hiura T, Osanai Y, Shouji A, Ujibe M, Ohtake T, Kimura K, Ishikawa M. (2005) Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice. Biological and Pharmaceutical Bulletin, 28, 527-530.
32. Kanno S, Tomizawa A, Ohtake T, Koiwai K, Ujibe M, Ishikawa M. (2006) Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicology Letters, 166, 131-139.
33. Li WW, Li VW, Hutnik M, Chiou AS. (2012) Tumor angiogenesis as a target for dietary cancer prevention. Journal of Oncology, 2012, 879623e.
34. Lou C, Zhang F, Yang M, Zhao J, Zeng W, Fang X, Zhang Y, Zhang C, Liang W. (2012) Naringenin decreases invasiveness and metastasis by inhibiting TGF-β -induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS ONE, 7, e50956.
35. Park JH, Jin CY, Lee BK, Kim GY, Choi YH, Yeong YK. (2008) Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1cells. Food and Chemical Toxicology, 46, 3684-3690.
36. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.
37. Ohno M, Abe T. (1991) Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). Journal of Immunological Methods, 145, 199-203.
38. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Research, 47, 3239-3245.
39. Partridge G, Flaherty P. (2009) An In vitro FluoroBlok tumor invasion assay. Journal of Visualized Experiments, 29, 1475e; doi: 10.3791/1475.